Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rose

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
European Heart Journal. Case Reports|July 13, 2022
Case report of an S-ICD implantation for secondary prevention in a patient with complex congenital heart disease, dextrocardia, and situs solitusFelix Wiedmann, Raffaele De Simone, Peter Rose, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|March 2, 2011
Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgeryAndreas K Demetriades, Nicholas Saunders, Peter Rose, et al.
Thrombosis and Haemostasis|January 4, 2007
The R2464C missense mutation in the von Willebrand factor gene causes a novel abnormality of multimer electrophoretic mobility and falls into the subgroup of type 2 von Willebrand disease 'unclassified'William A Lester, Andrea M Guilliatt, M Said Enayat, et al.
The Journal of the American Academy of Orthopaedic Surgeons|March 27, 2014
Oncologic conditions that simulate common sports injuriesAaron Krych, Andrew Odland, Peter Rose, et al.
Clinical Therapeutics|March 19, 2013
Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteersSreeraj Macha, Regina Sennewald, Peter Rose, et al.
Obstetrics and Gynecology International|June 20, 2013
Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survivalAmelia M Jernigan, Amanda Nickles Fader, Benjamin Nutter, et al.
Clinical Pharmacokinetics|February 16, 2020
Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I TrialManuela Vay, Marleen Julia Meyer, Antje Blank, et al.
World Journal of Gastroenterology|July 5, 2005
Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosisPeter Rose, Philip-K Moore, Shen-Han Ming, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Pharmacokinetics of linagliptin in subjects with hepatic impairmentUlrike Graefe-Mody, Peter Rose, Silke Retlich, et al.
Community Genetics|February 13, 2004
Pilot study of early diagnosis of hereditary haemochromatosis through systematic case finding in primary careJon Emery, Peter Rose, Jean Harcourt, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
European Heart Journal. Case Reports|July 13, 2022
Case report of an S-ICD implantation for secondary prevention in a patient with complex congenital heart disease, dextrocardia, and situs solitusFelix Wiedmann, Raffaele De Simone, Peter Rose, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|March 2, 2011
Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgeryAndreas K Demetriades, Nicholas Saunders, Peter Rose, et al.
Thrombosis and Haemostasis|January 4, 2007
The R2464C missense mutation in the von Willebrand factor gene causes a novel abnormality of multimer electrophoretic mobility and falls into the subgroup of type 2 von Willebrand disease 'unclassified'William A Lester, Andrea M Guilliatt, M Said Enayat, et al.
The Journal of the American Academy of Orthopaedic Surgeons|March 27, 2014
Oncologic conditions that simulate common sports injuriesAaron Krych, Andrew Odland, Peter Rose, et al.
Clinical Therapeutics|March 19, 2013
Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteersSreeraj Macha, Regina Sennewald, Peter Rose, et al.
Obstetrics and Gynecology International|June 20, 2013
Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survivalAmelia M Jernigan, Amanda Nickles Fader, Benjamin Nutter, et al.
Clinical Pharmacokinetics|February 16, 2020
Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I TrialManuela Vay, Marleen Julia Meyer, Antje Blank, et al.
World Journal of Gastroenterology|July 5, 2005
Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosisPeter Rose, Philip-K Moore, Shen-Han Ming, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Pharmacokinetics of linagliptin in subjects with hepatic impairmentUlrike Graefe-Mody, Peter Rose, Silke Retlich, et al.
Community Genetics|February 13, 2004
Pilot study of early diagnosis of hereditary haemochromatosis through systematic case finding in primary careJon Emery, Peter Rose, Jean Harcourt, et al.
Pageof 16